Drug ID: | NPD6186 |
Drug Name: | Ibrutinib |
Molecular Formula: | C25H24N6O2 |
Canonical SMILES: | C=CC(=O)N1CCC[C@H](C1)n1nc(c2c1ncnc2N)c1ccc(cc1)Oc1ccccc1 |
Standard InCHI: | InChI=1S/C25H24N6O2/c1-2-21(32)30-14-6-7-18(15-30)31-25-22(24(26)27-16-28-25)23(29-31)17-10-12-20(13-11-17)33-19-8-4-3-5-9-19/h2-5,8-13,16,18H,1,6-7,14-15H2,(H2,26,27,28)/t18-/m1/s1 |
Standard InCHIKey: | XYFPWWZEPKGCCK-GOSISDBHSA-N |
Max Developmental Stage: | Approved |
Max Developmental Stage Source: | TTD; ChEMBL; IUPHAR/BPS |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient
Tanimoto coefficient is calculated based on PubChem 881-bit substructure fingerprints.
High Similarity Level: Tc>=0.85; Intermediate Similarity Level: 0.7 <= Tc < 0.85; Remote Similarity Level: 0.65 <= Tc < 0.7
TTD | DNCL002550 |
DrugBank | DB09053 |
ChEMBL | CHEMBL1873475 |
IUPHAR/BPS | 6912 |
PharmaGKB | |
KEGG Drug | D10223 |
PubChem CID | 24821094 |
ChEBI | 76612 |
CAS Number | 936563-96-1 |
Molecular Weight | 440.20 |
ALogP | -1.528 |
MLogP | 3.33 |
XLogP | 4.182 |
HDA | 7 |
HBD | 1 |
Rotatable Bonds | 7 |
TPSA | 99.16 |
RO5 Violation | 0 |